Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

作者: Alan Sandler , Robert Gray , Michael C. Perry , Julie Brahmer , Joan H. Schiller

DOI: 10.1056/NEJMOA061884

关键词: PemetrexedInternal medicineCediranibHazard ratioCarboplatinMedicineGastroenterologyRespiratory diseaseSurgeryLung cancerMotesanibBevacizumab

摘要: Background Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to benefit patients with a variety of cancers. Methods Between July 2001 …

参考文章(24)
Christopher Jennison, Bruce W. Turnbull, Interim analyses: the repeated confidence interval approach Journal of the royal statistical society series b-methodological. ,vol. 51, pp. 305- 334 ,(1989) , 10.1111/J.2517-6161.1989.TB01433.X
Eleanor J. Manseau, Brygida Berse, Kathi Tognazzi, Donald R. Senger, Lawrence F. Brown, Harold F. Dvorak, Robert W. Jackman, Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and Its Receptors in Adenocarcinomas of the Gastrointestinal Tract Cancer Research. ,vol. 53, pp. 4727- 4735 ,(1993)
K Jin Kim, Bing Li, Jane Winer, Mark Armanini, Nancy Gillett, Heidi S Phillips, Napoleone Ferrara, None, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature. ,vol. 362, pp. 841- 844 ,(1993) , 10.1038/362841A0
Napoleone Ferrara, None, The role of vascular endothelial growth factor in pathological angiogenesis Breast Cancer Research and Treatment. ,vol. 36, pp. 127- 137 ,(1995) , 10.1007/BF00666035
Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter, None, The biology of VEGF and its receptors. Nature Medicine. ,vol. 9, pp. 669- 676 ,(2003) , 10.1038/NM0603-669
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, M. J. Thun, Cancer statistics, 2005. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 10- 30 ,(2005) , 10.3322/CANJCLIN.55.1.10
Douglas Hanahan, Robert A Weinberg, The hallmarks of cancer. Cell. ,vol. 100, pp. 57- 70 ,(2000) , 10.1016/S0092-8674(00)81683-9
Joan H. Schiller, David Harrington, Chandra P. Belani, Corey Langer, Alan Sandler, James Krook, Junming Zhu, David H. Johnson, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. The New England Journal of Medicine. ,vol. 346, pp. 92- 98 ,(2002) , 10.1056/NEJMOA011954